Myxoma Virus Oncolytic Efficiency Can Be Enhanced Through Chemical or Genetic Disruption of the Actin Cytoskeleton

Open Access

Peer-reviewed

Research Article

Chad R. Irwin,

Affiliation Department of Medical Microbiology & Immunology, University of Alberta, Edmonton Alberta, Canada
⨯
Nicole A. Favis,

Affiliation Department of Medical Microbiology & Immunology, University of Alberta, Edmonton Alberta, Canada
⨯
Kate C. Agopsowicz,

Affiliation Department of Oncology, University of Alberta, Edmonton Alberta, Canada
⨯
Mary M. Hitt,

Affiliations Department of Oncology, University of Alberta, Edmonton Alberta, Canada, Li Ka-Shing Institute of Virology, University of Alberta, Edmonton Alberta, Canada
⨯
David H. Evans

* E-mail: devans@ualberta.ca

Affiliations Department of Medical Microbiology & Immunology, University of Alberta, Edmonton Alberta, Canada, Li Ka-Shing Institute of Virology, University of Alberta, Edmonton Alberta, Canada
⨯

Reader Comments (0)

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Actins
Is the Subject Area "Actins" applicable to this article?

Thanks for your feedback.
Breast tumors
Is the Subject Area "Breast tumors" applicable to this article?

Thanks for your feedback.
Oncolytic viruses
Is the Subject Area "Oncolytic viruses" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cytoskeleton
Is the Subject Area "Cytoskeleton" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.